Skip to main content

Table 1 Data from patients used for MethylCap-seq and bisulfite sequencing validation

From: Genome-wide DNA methylation profiling of non-small cell lung carcinomas

Sample ID Tissue type Patient ID Stage Overall survival (month) Survival status Gender Age at diagnosis Ethnicity
2213 N healthy SCC1 IIB 2,43 Alive M 54,54 Caucasian
2214 T SCC
2235 N healthy SCC2 IIB 51,23 Deceased M 73,73 Caucasian
2236 T SCC
2245 N healthy ADC1 IB 12,57 Alive F 66,26 Caucasian
2246 T ADC
2255 N healthy ADC2 IA 98,93 Deceased F 54,26 Caucasian
2256 T ADC
2257 N healthy ADC3 N/A N/A N/A M 78,96 Caucasian
2258 T ADC
2261 N healthy SCC3 IIB 6,77 Alive M 70,03 Caucasian
2262 T SCC
22he healthy LCC1 IB 35,73 Deceased F 56,58 Caucasian
22tu LCC
  1. ADC: adenocarcinoma; LCC: large cell carcinoma; N/A: not applicable; SCC: Squamous cell carcinoma.